Phase IIa Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of M2951 in Subjects With Rheumatoid Arthritis on Stable Methotrexate Therapy
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 02 Jun 2017
At a glance
- Drugs Evobrutinib (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors EMD Serono
- 07 Jun 2017 Biomarkers information updated
- 25 May 2017 Planned End Date changed from 1 Oct 2017 to 14 Nov 2017.
- 27 Feb 2017 Planned End Date changed from 1 Sep 2017 to 1 Oct 2017.